The Department of Pharmaceutical Products proposes to oversee the drug regulator, Health News, ET HealthWorld

[ad_1]

New Delhi: Department of drugs (DoP) has suggested that the supervision of the Central Drugs Standard Control Organization (CDSCO) is transferred to it as the government is planning a major overhaul of the country drug authority. According to media reports, concerns have been raised at the highest levels of government over the regulatory framework’s ability to keep up with the demands of industry and researchers, triggering steps to upgrade the drug authority.

That cabinet Secretary had put together a committee tasked with reforming the drug regulation system chaired by Rajesh Bhushan, who will take over as health secretary to current health secretary Preeti Sudan after three months. The committee will meet on Friday according to the order to which ET has been granted access.

The Department of Pharmaceutical Products proposes to oversee the drug regulator

The DoP is of the opinion that as it deals with the pharmaceutical industry, CSDCO should fall within its scope. According to DoP, this will reduce unnecessary time delay in approving a drug or vaccine. “There are several agencies involved in the regulatory framework for a drug / vaccine approval. DoP has too National Pharmaceutical Price Authority below it, ”said an official who did not want to be identified. “It makes even more sense for the pharma department to take over drug regulation. DoP has proposed moving CDSCO during its charge. “

Friday meeting attends officials of the Ministry of Health, joint secretary in DoP, officials from the Department of Biotechnology, CDSCO and ICMR, and pharma executives.



[ad_2]

Source link